PEGINTERFERON BETA-1A for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where PEGINTERFERON BETA-1A was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for PEGINTERFERON BETA-1A
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Influenza like illness | 1,431 | 11.5% | 2 | 174 |
| Injection site erythema | 1,041 | 8.4% | 0 | 119 |
| Multiple sclerosis relapse | 945 | 7.6% | 2 | 578 |
| Fatigue | 673 | 5.4% | 2 | 142 |
| Headache | 587 | 4.7% | 0 | 105 |
| Pain | 580 | 4.7% | 2 | 111 |
| Injection site reaction | 569 | 4.6% | 1 | 51 |
| Device malfunction | 567 | 4.6% | 0 | 9 |
| Multiple sclerosis | 536 | 4.3% | 14 | 153 |
| Pyrexia | 503 | 4.0% | 4 | 135 |
| Memory impairment | 455 | 3.7% | 1 | 45 |
| Malaise | 448 | 3.6% | 3 | 101 |
| Injection site pain | 435 | 3.5% | 0 | 35 |
| Fall | 406 | 3.3% | 5 | 214 |
| Drug dose omission | 389 | 3.1% | 0 | 12 |
Other Indications for PEGINTERFERON BETA-1A
Multiple sclerosis (11,105)
Product used for unknown indication (817)
Relapsing-remitting multiple sclerosis (390)
Maternal exposure timing unspecified (82)
Demyelination (7)
Relapsing multiple sclerosis (6)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)